# Prevention of Maternal and Fetal Metabolic Complications With Diet and Nutraceutical Supplementation in Pregnant Women Affected by Gestational Diabetes: a Randomized, Double-blind Placebo Controlled Trial.

> **NCT05393843** · PHASE4 · TERMINATED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 51 (actual)

## Conditions studied

- Gestational Diabetes
- Oxidative Stress

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 fatty acids, anthocyanins and alpha-cyclodextrins
- **BEHAVIORAL:** diet
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05393843
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** outbreak of covid pandemic that caused problems with nutritional coaching in person.
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393843, "Prevention of Maternal and Fetal Metabolic Complications With Diet and Nutraceutical Supplementation in Pregnant Women Affected by Gestational Diabetes: a Randomized, Double-blind Placebo Controlled Trial.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05393843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*